Cover Image
Read Now

Off-label use of intravenous immunoglobulin for dermatological conditions a review of clinical effectiveness

This Rapid Response report aims to review the comparative effectiveness of intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) for off-label use for dermatological conditions, and is complementary to the 2017 CADTH Rapid Response, Summary of Abstracts report: "Off-Label Use...

Full description

Bibliographic Details
Main Authors: Ho, Chuong, Visintini, Sarah (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, 2018
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Skin Diseases / Drug Therapy
Off-label Use
Treatment Outcome
Immunoglobulins, Intravenous / Therapeutic Use
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:This Rapid Response report aims to review the comparative effectiveness of intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) for off-label use for dermatological conditions, and is complementary to the 2017 CADTH Rapid Response, Summary of Abstracts report: "Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: Clinical Effectiveness"
Physical Description:1 PDF file (21 pages) illustrations

Similar Items